Evidence map›Paper›PMID 36945637›Full record

ArticlebioRxiv : the preprint server for biology2025

Tyrosinase-induced neuromelanin accumulation triggers rapid dysregulation and degeneration of the mouse locus coeruleus.

Alexa F Iannitelli, Leslie Hassanein, Margaret M Tish, Bernard Mulvey, Harris E Blankenship, Anu Korukonda, L Cameron Liles, Amanda L Sharpe, Jean-Francoise Pare, Rosa Villalba and 8 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Lignans inFrontiers in plant science · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Alexa F IannitelliDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Leslie HassaneinDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Margaret M TishDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Bernard MulveyDepartment of Psychiatry, Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Harris E BlankenshipAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Anu KorukondaDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
L Cameron LilesDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Amanda L SharpeDepartment of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, 73117.
Jean-Francoise PareDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Rosa VillalbaDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Arielle SegalDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Steven A SloanDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Keri MartinowichLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA.
Joseph D DoughertyDepartment of Psychiatry, Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Katharine E McCannDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Yoland SmithDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Michael J BecksteadAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Emory University · USJohns Hopkins University · USOklahoma Medical Research Foundation · USWashington University in St. Louis · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Graduate and Postdoctoral Training in ToxicologyT32ES012870 · NIEHS · EMORY UNIVERSITY · PI Carmen Joseph Marsit · 2004 to 2026
$9.1M
Mechanisms underlying selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG061175 · NIA · EMORY UNIVERSITY · PI KANG, SEONG SU, WEINSHENKER, DAVID · 2019 to 2019
$2.8M
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG079199 · NIA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2022 to 2024
$1.6M
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseR01AG079199 · NIA · EMORY UNIVERSITY · PI DAVID WEINSHENKER · 2025 to 2026
$1.0M
Investigating Neuromelanin-Mediated Locus Coeruleus Neurodegeneration in a Novel Mouse Model of Parkinson's DiseaseF99NS129168 · NINDS · EMORY UNIVERSITY · PI IANNITELLI, ALEXA FAITH · 2022 to 2022
$46k
NCATS NIH HHS UL1 TR002378NIA NIH HHS R01 AG079199NIA NIH HHS RF1 AG061175NIA NIH HHS RF1 AG079199NIEHS NIH HHS T32 ES012870NIH HHS P51 OD011132NINDS NIH HHS F99 NS129168
6 · The paper itself

Abstract

The locus coeruleus (LC), the major source of norepinephrine (NE) in the brain, is among the earliest site of pathology in both Alzheimer's disease (AD) and Parkinson's disease (PD), and it undergoes catastrophic degeneration later in both disorders. Dysregulation of the LC is thought to contribute to prodromal symptoms of AD and PD such as anxiety and sleep disturbances, while frank LC loss promotes cognitive decline. However, the mechanisms responsible for its selective vulnerability are unknown. It has been suggested that neuromelanin (NM) pigment contributes to LC susceptibility, but causal relationships have been difficult to test because rodents do not naturally produce NM. Here, we report that viral-mediated expression of human tyrosinase induced pigmentation in mouse LC neurons that recapitulated key features of natural primate NM. One week of NM accumulation resulted in LC neuron hyperactivity, reduced tissue NE levels, transcriptional changes, and anxiety-like behavior. By 6-10 weeks, NM accumulation was associated with severe LC neuron neurodegeneration and microglial engulfment of the pigment granules, while the anxiety-like behavior abated. These phenotypes are reminiscent of LC dysfunction and cell death in AD and PD, validating this model for studying the consequences of NM accumulation in the LC as it relates to neurodegenerative disease.

Identifiers

PMID36945637
PMCPMC10028911
OpenAlexW4323827196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.